Hristina I. Pashova

Tooth wear: prevalence and associated factors in general practice patients

Joana Cunha‐Cruz, Hristina I. Pashova, J. D. Packard et al. · Community Dentistry And Oral Epidemiology · 2010 · 83 citations

Dentistry, Dental Public Health, Pediatric Dentistry +12

Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial

Alexander Olawaiye, Laurence Gladieff, David M. O’Malley et al. · The Lancet · 2025 · 46 citations

Medicine, Oncology, Pharmacology +13

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study

Nicoletta Colombo, Toon Van Gorp, Ursula A. Matulonis et al. · Journal of Clinical Oncology · 2023 · 37 citations · Full text

Medicine, Oncology, Pharmacology +16

Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors

Pamela N. Münster, Andrew E. Greenstein, Gini F. Fleming et al. · Clinical Cancer Research · 2022 · 33 citations · Full text

Medicine, Oncology, Pharmacology +15

Association between caries location and restorative material treatment provided

Erinne B. Lubisich, Thomas J. Hilton, Jack L. Ferracane et al. · Journal of Dentistry · 2011 · 22 citations

Dentistry, Periodontics, Restorative Dentistry +13